Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: IBS1BZ4E4I

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Programmed cell death protein 1 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hodgkin Disease 3 D006689 ClinicalTrials
Carcinoma, Squamous Cell 3 D002294 ClinicalTrials
Carcinoma, Hepatocellular 3 D006528 ClinicalTrials
Lung Neoplasms 3 D008175 ClinicalTrials
Carcinoma, Squamous Cell 3 D002294 ClinicalTrials
Hodgkin Disease 3 D006689 ClinicalTrials
Nasopharyngeal Carcinoma 3 D000077274 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Glioblastoma 2 D005909 ClinicalTrials
Lymphoma, Large B-Cell, Diffuse 2 D016403 ClinicalTrials
Small Cell Lung Carcinoma 2 D055752 ClinicalTrials
Essential Tremor 2 D020329 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Thyroid Neoplasms 2 D013964 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Nasopharyngeal Neoplasms 2 D009303 ClinicalTrials
Pheochromocytoma 2 D010673 ClinicalTrials
Paraganglioma 2 D010235 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 2 D002289 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297571
FDA SRS IBS1BZ4E4I